ARTÍCULOS DE QUIMI-VIO

DISEÑO, CARACTERIZACIÓN Y ESTUDIOS PRECLÍNICOS

High-performance reverse phase chromatography with fluorescence detection assay for characterization and quantification of pneumococcal polysaccharides
Enzyme-linked immunosorbent assay for quantitative determination of capsular polysaccharide production in Streptococcus pneumoniae clinical isolates
Identidad de la vacuna contra Streptococcus pneumoniae “Quimi-Vio” mediante la técnica Dot Blot empleando los anticuerpos monoclonales contra los polisacáridos capsulares 1,5, 6B, 14 y 19F de la bacteria
Immunoagglutination Test Using Monoclonal Antibodies Coupled to Latex Particles to Identify The Streptococcus Pneumoniae Capsular Polysaccharides Serotype 1, 5, 6B, 14 And 19F In Quimi-Vio Vaccine
Expanding the Scope of Ugi Multicomponent Bioconjugation to Produce Pneumococcal Multivalent Glycoconjugates as Vaccine Candidates
Influence of the Co-Administration of Heptavalent Conjugate Vaccine PCV7-TT on the Immunological Response Elicited by VA-MENGOC-BC® and Heberpenta®-L in Rabbits
Relevance of O-acetyl and phosphoglycerol groups for the antigenicity of Streptococcus pneumoniae serotype 18C capsular polysaccharide
Procedure for the conjugation of the Streptococcus pneumoniae serotype 6B capsular polysaccharide to the tetanus toxoid
Activación del polisacárido capsular de Streptococcus pneumoniae serotipo 23F para la obtención de vacunas conjugadas
Quantitative assessment of C-polysaccharide in capsularpolysaccharides of Streptococcus pneumoniae by31PNMR
Effect of O-Acetylation on the Antigenicity and Glycoconjugate Immunogenicity of the Streptococcus Pneumoniae Serotype 7F Capsular Polysaccharide
Preclinical toxicity of Cuban pneumococcal conjugate vaccine candidate PCV7-TT

ESTUDIOS CLÍNICOS Y OTROS

Cost-effectiveness of introducing a domestic pneumococcal conjugate vaccine (PCV7-TT) into the Cuban national immunization programme
Safety and Immunogenicity of Cuban Antipneumococcal Conjugate Vaccine PCV7-TT in Healthy Adults
Safety and preliminary immunogenicity of Cuban pneumococcal conjugate vaccine candidate in healthy children: A randomized phase I clinical trial
Safety and immunogenicity of the Cuban heptavalent pneumococcal conjugate vaccine in healthy infants. Results from a double-blind randomized control trial Phase I
From individual to herd protection with pneumococcal vaccines: the contribution of the Cuban pneumococcal conjugate vaccine implementation strategy
La nueva vacuna cubana antineumocócica, de las evidencias científicas disponibles, a la estrategia de evaluación clínica y de impacto
Safety and immunogenicity of the Cuban heptavalent pneumococcal conjugate vaccine in healthy infants. Results from a double-blind randomized control trial Phase I
Burden of pneumococcal disease in children in Cuba before the introduction of a novel pneumococcal conjugate vaccine
Colonización nasofaríngea por Streptococus pneumoniae en niños prescolares cubanos: encuestas transversales antes-después de la vacunación antineumocócica
Evaluation Strategy to Support the Introduction the New Cuban Conjugated Pneumococcal Vaccine in the National Health System